Zabaleta launches Christie treatment centre
- 23 November 2010 16:42
- Posted by Tim Oscroft
Pablo Zabaleta visited The Christie today to mark the opening of the hospital’s new world-leading patient treatment centre.
The £35million facility is on the site of the existing hospital and houses the UK’s biggest chemotherapy facility as well as the world’s largest early clinical trials unit.
The popular Argentinean chatted with City fans Michael Ambrose and Jerry Ogbewi, two of the first patients to be treated in the new centre’s teenage cancer unit.
“The Christie is giving people a great chance to get the best treatment, and I was really impressed with the new facility,” Pablo told MCFC.co.uk. “It is going to make a massive difference to people with cancer in this area and I want to wish all the patients and staff well for the future.”
The Christie, based in Withington in south Manchester, has been an international leader in cancer research for more than 100 years. The new centre will double the number of early trials which can be undertaken, testing the newest drugs on cancer patients for whom standard cancer treatments have failed to work.
The centre will see 700 patients every week, treating over 200 different types of cancer with hundreds of different types of chemotherapy and new cancer drugs
Sarah Lynch, MD of City’s community scheme CITC, said:
“The Christie is a truly world-leading resource and one which is a source of tremendous pride to the city. This new treatment centre will help to save the lives of thousands of people, both locally and also across the globe through the research which will take place here. We are very pleased to show our support of such a fantastic addition to the already outstanding work achieved at The Christie.”
Alicia Custis, Head of Communications added: “We are so grateful for the fantastic support of Man City and our patients were really excited to meet Pablo Zabaleta. This new centre will give local cancer patients the best possible care and enable us to undertake even more research, ultimately saving lives across the world.”